Thai vaccine to enter third phase of trials

2021-11-18

Chulalongkorn University’s Centre of Excellence in Vaccine Research and Development expects to register its mRNA Covid-19 vaccine, known as ChulaCOV-19, mid-next year.

Source : https://www.bangkokpost.com/thailand/general/2217743/thai-vaccine-to-enter-third-phase-of-trials

SPH stands ready to continue on its own if shareholders do not approve privatisation offers

Dutch weigh options to slow rising COVID-19 infections among children

Thai vaccine to enter third phase of trials

Latest Articles

Beyond attracting MNCs, EDB to grow next generation of global business champions

Asian Airlines Prioritize Profitability as Global Aviation Enters a More Disciplined Phase

Chip Equipment Industry Deepens Investment Across Asia as Demand for Advanced Manufacturing Grows

Malaysia’s growth unexpectedly surges to 5.8% on exports

More ships to call at S’pore? How the Iran war, tariffs are reshaping global sea trade

DeepSeek champions China’s bid to flood the world with cheap AI